X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Surya Pharmaceutical Ltd.
BSE CODE: 532516   |   NSE CODE: NA   |   ISIN CODE : INE249G01020   |   14-Sep-2015 Hrs IST
BSE NSE
Rs. 0.16
0 ( 0% )
 
Prev Close ( Rs.)
0.16
Open ( Rs.)
0.16
 
High ( Rs.)
0.16
Low ( Rs.)
0.16
 
Volume
234695
Week Avg.Volume
270910
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
163983
 
52 WK High-Low Range(Rs.)
Particulars Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009
Operational & Financial Ratios          
   Earnings Per Share (Rs)-14.89  -13.47  5.20  52.57  38.79  
   CEPS(Rs)-11.80  -11.76  6.57  6.68  4.99  
   DPS(Rs)0.00  0.00  0.15  1.50  1.20  
   Book NAV/Share(Rs)-2.68  12.21  26.63  208.13  158.46  
   Tax Rate(%)34.20  30.53  23.96  15.92  12.43  
Margin Ratios          
   Core EBITDA Margin(%)-266.57  -11.19  16.07  14.07  15.51  
   EBIT Margin(%)-389.67  -13.01  14.66  13.20  14.01  
   Pre Tax Margin(%)-709.84  -23.83  8.06  7.82  8.53  
   PAT Margin (%)-467.04  -16.55  6.13  6.57  7.47  
   Cash Profit Margin (%)-370.38  -14.46  7.76  8.35  9.60  
Performance Ratios          
   ROA(%)-15.89  -13.03  5.64  6.51  7.15  
   ROE(%)-312.51  -71.80  24.59  28.68  27.57  
   ROCE(%)-12.73  -10.84  16.12  17.57  17.17  
   Asset Turnover(x)0.03  0.79  0.92  0.99  0.96  
   Sales/Fixed Asset(x)0.07  2.37  3.93  3.91  3.08  
   Working Capital/Sales(x)-0.08  -3.54  8.45  1.97  1.70  
Efficiency Ratios          
   Fixed Capital/Sales(x)13.57  0.42  0.25  0.26  0.33  
   Receivable days1302.53  58.29  49.60  45.78  53.56  
   Inventory Days4068.63  204.93  189.72  162.46  148.15  
   Payable days75.22  12.73  49.24  90.49  87.75  
Valuation Parameters          
   PER(x)0.00  0.00  4.71  3.37  1.38  
   PCE(x)-0.10  -0.92  3.73  2.65  1.07  
   Price/Book(x)-0.43  0.89  0.92  0.85  0.34  
   Yield(%)0.00  0.00  0.61  0.85  2.25  
   EV/Net Sales(x)33.57  1.21  1.19  0.83  0.79  
   EV/Core EBITDA(x)-11.81  -10.90  7.13  5.46  4.70  
   EV/EBIT(x)-8.04  -9.15  7.93  6.19  5.41  
   EV/CE(x)1.14  0.97  0.88  0.68  0.60  
   M Cap / Sales0.39  0.14  0.30  0.23  0.11  
Growth Ratio          
   Net Sales Growth(%)-96.28  1.41  41.11  56.88  48.59  
   Core EBITDA Growth(%)4.81  -167.69  53.43  42.93  32.44  
   EBIT Growth(%)-17.29  -189.65  56.70  45.19  28.00  
   PAT Growth(%)-10.49  -372.72  31.68  35.51  34.56  
   EPS Growth(%)-10.49  -359.27  -90.12  35.51  34.56  
Financial Stability Ratios          
   Total Debt/Equity(x)-36.98  7.09  2.81  2.35  2.18  
   Current Ratio(x)0.54  0.72  1.15  2.63  3.17  
   Quick Ratio(x)0.19  0.22  0.36  0.81  1.34  
   Interest Cover(x)-1.22  -1.20  2.22  2.45  2.56  
   Total Debt/Mcap(x)86.17  8.00  3.05  2.76  6.48